nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acute promyelocytic leukemia: What is the new standard of care?
|
Watts, Justin M. |
|
2014 |
|
5 |
p. 205-212 8 p. |
artikel |
2 |
Anti-CD20 monoclonal antibodies: Beyond B-cells
|
Avivi, Irit |
|
2013 |
|
5 |
p. 217-223 7 p. |
artikel |
3 |
Antithrombotic drugs, patient characteristics, and gastrointestinal bleeding: Clinical translation and areas of research
|
Di Minno, Alessandro |
|
2015 |
|
5 |
p. 335-343 9 p. |
artikel |
4 |
An update of the mutation profile of Factor 13 A and B genes
|
Biswas, Arijit |
|
2011 |
|
5 |
p. 193-204 12 p. |
artikel |
5 |
Approach to pancytopenia: Diagnostic algorithm for clinical hematologists
|
Gnanaraj, Jerome |
|
2018 |
|
5 |
p. 361-367 |
artikel |
6 |
Autophagy: A necessary event during erythropoiesis
|
Grosso, Rubén |
|
2017 |
|
5 |
p. 300-305 6 p. |
artikel |
7 |
Autophagy as a target for hematological malignancy therapy
|
Dong, Zhiwu |
|
2016 |
|
5 |
p. 369-380 12 p. |
artikel |
8 |
Basic mechanisms and pathogenesis of venous thrombosis
|
Esmon, Charles T. |
|
2009 |
|
5 |
p. 225-229 5 p. |
artikel |
9 |
Biomechanics of lower limb haemophilic arthropathy
|
Stephensen, David |
|
2012 |
|
5 |
p. 213-221 9 p. |
artikel |
10 |
Bleeding in the heritable connective tissue disorders: Mechanisms, diagnosis and treatment
|
Malfait, Fransiska |
|
2009 |
|
5 |
p. 191-197 7 p. |
artikel |
11 |
Blood flow and mass transfer regulation of coagulation
|
Rana, Kuldeepsinh |
|
2016 |
|
5 |
p. 357-368 12 p. |
artikel |
12 |
Catalyzing improvements in ALL therapy with asparaginase
|
Marini, Bernard L. |
|
2017 |
|
5 |
p. 328-338 11 p. |
artikel |
13 |
Cereblon binding molecules in multiple myeloma
|
Kortüm, K.M. |
|
2015 |
|
5 |
p. 329-334 6 p. |
artikel |
14 |
Chronic lymphocytic leukemia and infection risk in the era of targeted therapies: Linking mechanisms with infections
|
Hilal, Talal |
|
2018 |
|
5 |
p. 387-399 |
artikel |
15 |
Chronic myelomoncytic leukemia: Are we finally solving the identity crisis?
|
Nazha, Aziz |
|
2016 |
|
5 |
p. 381-388 8 p. |
artikel |
16 |
Current therapy of myelodysplastic syndromes
|
Zeidan, Amer M. |
|
2013 |
|
5 |
p. 243-259 17 p. |
artikel |
17 |
Dancing partners at the ball: Rational selection of next generation anti-CD20 antibodies for combination therapy of chronic lymphocytic leukemia in the novel agents era
|
Butler, L.A. |
|
2017 |
|
5 |
p. 318-327 10 p. |
artikel |
18 |
Does percutaneous coronary stent implantation increase platelet reactivity?
|
Janssen, P.W.A. |
|
2017 |
|
5 |
p. 271-275 5 p. |
artikel |
19 |
Editorial Board
|
|
|
2009 |
|
5 |
p. i- 1 p. |
artikel |
20 |
Emerging options in the treatment of deep vein thrombosis and pulmonary embolism
|
Brenner, Benjamin |
|
2011 |
|
5 |
p. 215-221 7 p. |
artikel |
21 |
Emerging therapies for patients with advanced chronic lymphocytic leukaemia
|
Delgado, Julio |
|
2009 |
|
5 |
p. 217-224 8 p. |
artikel |
22 |
Extramedullary acute myelogenous leukemia
|
Solh, Melhem |
|
2016 |
|
5 |
p. 333-339 7 p. |
artikel |
23 |
Front-line therapy in polycythemia vera and essential thrombocythemia
|
Barbui, Tiziano |
|
2012 |
|
5 |
p. 205-211 7 p. |
artikel |
24 |
G6PD deficiency: the genotype-phenotype association
|
Mason, Philip J |
|
2007 |
|
5 |
p. 267-283 17 p. |
artikel |
25 |
Haemoglobinopathy diagnosis: Algorithms, lessons and pitfalls
|
Bain, Barbara J. |
|
2011 |
|
5 |
p. 205-213 9 p. |
artikel |
26 |
Haemophilia gene therapy: Progress and challenges
|
Lheriteau, Elsa |
|
2015 |
|
5 |
p. 321-328 8 p. |
artikel |
27 |
Hairy cell leukemia: Update on molecular profiling and therapeutic advances
|
Grever, Michael R. |
|
2014 |
|
5 |
p. 197-203 7 p. |
artikel |
28 |
Hemophagocytic syndromes
|
Janka, Gritta E. |
|
2007 |
|
5 |
p. 245-253 9 p. |
artikel |
29 |
How I treat acute and chronic leukemia in pregnancy
|
Shapira, Tal |
|
2008 |
|
5 |
p. 247-259 13 p. |
artikel |
30 |
Immunodeficiency-associated lymphomas
|
Tran, Huy |
|
2008 |
|
5 |
p. 261-281 21 p. |
artikel |
31 |
Immunotherapeutic strategies for relapse control in acute myeloid leukemia
|
Martner, Anna |
|
2013 |
|
5 |
p. 209-216 8 p. |
artikel |
32 |
Infections associated with purine analogs and monoclonal antibodies
|
Ravandi, Farhad |
|
2005 |
|
5 |
p. 253-273 21 p. |
artikel |
33 |
Information transfer by exosomes: A new frontier in hematologic malignancies
|
Boyiadzis, Michael |
|
2015 |
|
5 |
p. 281-290 10 p. |
artikel |
34 |
Interleukin-1β as emerging therapeutic target in hematological malignancies and potentially in their complications
|
Arranz, Lorena |
|
2017 |
|
5 |
p. 306-317 12 p. |
artikel |
35 |
Ironing out the details of iron overload in myelofibrosis: Lessons from myelodysplastic syndromes
|
Carreau, Nicole |
|
2016 |
|
5 |
p. 349-356 8 p. |
artikel |
36 |
JAK inhibitors in myeloproliferative neoplasms: Rationale, current data and perspective
|
Tefferi, A. |
|
2011 |
|
5 |
p. 229-237 9 p. |
artikel |
37 |
Management of Philadelphia negative chronic myeloproliferative disorders in pregnancy
|
Griesshammer, Martin |
|
2008 |
|
5 |
p. 235-245 11 p. |
artikel |
38 |
Molecular biology of mantle cell lymphoma: From profiling studies to new therapeutic strategies
|
Obrador-Hevia, Antònia |
|
2009 |
|
5 |
p. 205-216 12 p. |
artikel |
39 |
Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma
|
Rajkumar, S. Vincent |
|
2007 |
|
5 |
p. 255-265 11 p. |
artikel |
40 |
Musculo-skeletal manifestations of haemophilia
|
Rodriguez-Merchan, E. Carlos |
|
2016 |
|
5 |
p. 401-409 9 p. |
artikel |
41 |
Myeloid-derived suppressor cells: The green light for myeloma immune escape
|
Malek, Ehsan |
|
2016 |
|
5 |
p. 341-348 8 p. |
artikel |
42 |
New strategies of antifungal therapy in hematopoietic stem cell transplant recipients and patients with hematological malignancies
|
Leather, Helen L. |
|
2006 |
|
5 |
p. 267-287 21 p. |
artikel |
43 |
Non-Hodgkin lymphomas in pregnancy: Tackling therapeutic quandaries
|
Avivi, Irit |
|
2014 |
|
5 |
p. 213-220 8 p. |
artikel |
44 |
Pathogenesis of neutropenia in large granular lymphocyte leukemia and Felty syndrome
|
Burks, Eric J. |
|
2006 |
|
5 |
p. 245-266 22 p. |
artikel |
45 |
Practical issues surrounding the explosion of tyrosine kinase inhibitors for the management of chronic myeloid leukemia
|
Mathisen, Michael S. |
|
2014 |
|
5 |
p. 179-187 9 p. |
artikel |
46 |
Prognostication of diffuse large B-cell lymphoma in the molecular era: moving beyond the IPI
|
Wight, Joel C. |
|
2018 |
|
5 |
p. 400-415 |
artikel |
47 |
Radioimmunotherapy-based conditioning for hematopoietic stem cell transplantation: Another step forward
|
Ali, Alaa M. |
|
2016 |
|
5 |
p. 389-399 11 p. |
artikel |
48 |
Risk-adapted therapy in essential thrombocythemia and polycythemia vera
|
Finazzi, Guido |
|
2005 |
|
5 |
p. 243-252 10 p. |
artikel |
49 |
Should studies on Glanzmann thrombasthenia not be telling us more about cardiovascular disease and other major illnesses?
|
Nurden, Alan T. |
|
2017 |
|
5 |
p. 287-299 13 p. |
artikel |
50 |
Standing up to the cardiometabolic consequences of hematological cancers
|
Howden, Erin J. |
|
2018 |
|
5 |
p. 349-360 |
artikel |
51 |
Stem cell transplantation for indolent lymphoma
|
van Besien, Koen |
|
2011 |
|
5 |
p. 223-228 6 p. |
artikel |
52 |
Strategies targeting apoptosis proteins to improve therapy of chronic lymphocytic leukemia
|
Besbes, Samaher |
|
2015 |
|
5 |
p. 345-350 6 p. |
artikel |
53 |
Thalassemia and hypercoagulability
|
Taher, Ali T. |
|
2008 |
|
5 |
p. 283-292 10 p. |
artikel |
54 |
The bone marrow microenvironment – Home of the leukemic blasts
|
Shafat, Manar S |
|
2017 |
|
5 |
p. 277-286 10 p. |
artikel |
55 |
The evolving role of autologous and allogeneic stem cell transplantation in follicular lymphoma
|
Van Besien, Koen |
|
2006 |
|
5 |
p. 235-244 10 p. |
artikel |
56 |
The future of JAK inhibition in myelofibrosis and beyond
|
Mascarenhas, John O. |
|
2014 |
|
5 |
p. 189-196 8 p. |
artikel |
57 |
The molecular physiology and pathology of fibrin structure/function
|
Standeven, Kristina F. |
|
2005 |
|
5 |
p. 275-288 14 p. |
artikel |
58 |
The possible role of maintenance treatment for primary central nervous system lymphoma
|
Bairey, Osnat |
|
2018 |
|
5 |
p. 378-386 |
artikel |
59 |
Therapy of Relapsed Hodgkin Lymphoma
|
Cashen, Amanda F. |
|
2007 |
|
5 |
p. 233-243 11 p. |
artikel |
60 |
The roles of JAK2 in DNA damage and repair in the myeloproliferative neoplasms: Opportunities for targeted therapy
|
Karantanos, Theodoros |
|
2018 |
|
5 |
p. 426-432 |
artikel |
61 |
Thrombin generation: What have we learned?
|
Al Dieri, Raed |
|
2012 |
|
5 |
p. 197-203 7 p. |
artikel |
62 |
Thrombotic complications associated with stem cell transplantation
|
Nadir, Yona |
|
2012 |
|
5 |
p. 183-187 5 p. |
artikel |
63 |
Time to repeal and replace response criteria for acute myeloid leukemia?
|
Bloomfield, Clara Derber |
|
2018 |
|
5 |
p. 416-425 |
artikel |
64 |
To chelate or not to chelate in MDS: That is the question!
|
Zeidan, Amer M. |
|
2018 |
|
5 |
p. 368-377 |
artikel |
65 |
To serve and protect: The modulatory role of von Willebrand factor on factor VIII immunogenicity
|
Hartholt, Robin B. |
|
2017 |
|
5 |
p. 339-347 9 p. |
artikel |
66 |
Transfusions for anemia in adult and pediatric patients with malignancies
|
Shah, Neil |
|
2015 |
|
5 |
p. 291-299 9 p. |
artikel |
67 |
Transfusion strategies for traumatic coagulopathy
|
Curry, Nicola S. |
|
2012 |
|
5 |
p. 223-232 10 p. |
artikel |
68 |
Travel and thrombosis
|
Watson, Henry G. |
|
2005 |
|
5 |
p. 235-241 7 p. |
artikel |
69 |
Umbilical cord blood transplantation: Pros, cons and beyond
|
Stanevsky, Anfisa |
|
2009 |
|
5 |
p. 199-204 6 p. |
artikel |
70 |
Vena cava filters for management of venous thromboembolism: A clinical review
|
Rajasekhar, Anita |
|
2013 |
|
5 |
p. 225-241 17 p. |
artikel |
71 |
Von Willebrand factor deficiency and atherosclerosis
|
van Galen, K.P.M. |
|
2012 |
|
5 |
p. 189-196 8 p. |
artikel |
72 |
Waldenström macroglobulinemia: What a hematologist needs to know
|
Kapoor, Prashant |
|
2015 |
|
5 |
p. 301-319 19 p. |
artikel |